Xcout Intel
Verseon Corp
Verseon International Corporation is a clinical-stage pharmaceutical company based in Fremont, California. It is developing several drug discovery programs in cardiometabolic diseases and cancer featuring drug candidates that represent novel chemical matter designed using molecular physics and artificial intelligence.
Subscribe to see Verseon Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Verseon Corp at a glance
Verseon Corp is a company headquartered in United States, founded in 2002. Its most recent funding round, Debt, raised $1M in January 2020. Xcout tracks 1 named person at Verseon Corp, including Adityo Prakash (CEO).
Verseon Corp leadership
- Adityo PrakashCEO
Verseon Corp funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | $1M | 1 named | |
| SEC Form D filing | $101,400 | — | |
| SEC Form D filing | $451,000 | — | |
| SEC Form D filing | $69,827 | — | |
| SEC Form D filing | $259,573 | — | |
| SEC Form D filing | $11.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Verseon Corp competitors
A few of Verseon Corp's closest competitors — see the full list of competitors and alternatives →
Numerion Labs, headquartered in San Francisco, CA, USA, specializes in AI-based drug discovery services. The company employs a world-class team of scientists and engineers to redefine how small-molecule drugs are discovered using artificial intelligence.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Atomwise Inc. is an artificial intelligence-driven drug development company founded in 2012 and based in San Francisco, California. The company utilizes advanced AI technologies, such as its AtomNet PoseRanker, to discover novel medicines and accelerate pharmaceutical research.
PharmCADD is a South Korean biopharmaceutical company founded in 2019 and headquartered in Busan. The company applies artificial intelligence and physics-based modeling to drug discovery and development.
Variational AI is a privately held biotechnology startup headquartered in Vancouver, British Columbia. Founded in 2019, the company focuses on drug discovery, utilizing artificial intelligence to identify novel drug-like small molecules. Recognized as an innovative AI enterprise in Canada, it develops advanced computational methods for pharmaceutical research.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Get Verseon Corp's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Verseon Corp in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 8 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access